标题
Uncontrolled diabetes predicts poor response to novel antiandrogens
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 23, Issue 9, Pages 691-698
出版商
Bioscientifica
发表日期
2016-08-12
DOI
10.1530/erc-16-0222
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- (2016) Christopher P. Evans et al. EUROPEAN UROLOGY
- Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer
- (2015) Yohann Loriot et al. EUROPEAN JOURNAL OF CANCER
- Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort
- (2015) Bimal Bhindi et al. EUROPEAN UROLOGY
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Metformin effects on biochemical recurrence and metabolic signaling in the prostate
- (2015) Brian Winters et al. PROSTATE
- Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
- (2015) Vincenza Conteduca et al. PROSTATE
- Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis
- (2015) A D Raval et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Androgen Receptor Roles in Insulin Resistance and Obesity in Males: The Linkage of Androgen-Deprivation Therapy to Metabolic Syndrome
- (2014) I.-C. Yu et al. DIABETES
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period
- (2013) Jennifer N. Wu et al. CANCER
- The Relationship Between Glucose Metabolism, Metabolic Syndrome, and Bone-Specific Alkaline Phosphatase: A Structural Equation Modeling Approach
- (2013) Ching-Lung Cheung et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of metabolic syndrome on pathologic features of prostate cancer
- (2012) Emil Kheterpal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cancer cachexia: impact, mechanisms and emerging treatments
- (2012) Vanessa C. Vaughan et al. Journal of Cachexia Sarcopenia and Muscle
- The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
- (2011) Mei-Yueh Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-like growth factor pathway: A link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?
- (2011) Rahul R. Aggarwal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
- (2010) J. Flanagan et al. ANNALS OF ONCOLOGY
- Implications of Body Mass Index in Japanese Patients with Prostate Cancer Who Had Undergone Radical Prostatectomy
- (2010) A. Komaru et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Assessment of pain
- (2008) H. Breivik et al. BRITISH JOURNAL OF ANAESTHESIA
- Hypercholesterolemia and prostate cancer: a hospital-based case–control study
- (2008) Lindsay Magura et al. CANCER CAUSES & CONTROL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started